Article

Identification of common molecular biomarker signatures in blood and brain of Alzheimer’s disease

2018-11-29

Abstract excerpt

<h4>Background</h4> Alzheimers disease (AD) is a progressive neurodegenerative disease characterized by memory loss and confusion. Neuroimaging and cerebrospinal fluid-based early detection is limited in sensitivity and specificity as well as by cost. Therefore, detecting AD from blood cell analysis could improve early diagnosis and treatment of the disease. The present study aimed to identify blood cell transcri...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 486c836f-cc5f-5db2-a66f-c9220a9e65fb
DOI: 10.1101/482828

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of common molecular biomarker signatures in blood and brain of Alzheimer’s diseaseDOI 10.1101/482828Read

Blood Genome-Wide Transcriptional Profiles Reflect Broad Molecular Impairments and Strong Blood-Brain Links in Alzheimer's DiseaseSemantic proximity Read

Systematic Analysis and Biomarker Study for Alzheimer’s DiseaseSemantic proximity Read

Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimer’s disease: Insights from a systems biomedicine perspectiveSemantic proximity Read

Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratificationSemantic proximity Read

Blood-Based RNA Biomarkers and Machine Learning Approaches for Alzheimer’s DiseaseSemantic proximity Read

Identification of molecular signatures associated with sleep disorder and Alzheimer’s diseaseSemantic proximity Read

Distinctive RNA Expression Profiles in Blood Associated With Alzheimer Disease After Accounting for White Matter HyperintensitiesSemantic proximity Read

Exploratory Single-Cell RNA Sequencing of Peripheral Blood Identifies Candidate Signatures Associated with Alzheimer’s DiseaseSemantic proximity Read

Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspectiveSemantic proximity Read

Biological and Disease Hallmarks of Alzheimer’s Disease Defined by Alzheimer’s Disease GenesSemantic proximity Read

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegenerationSemantic proximity Read

Toward an Alzheimer's disease diagnosis via high‐resolution blood gene expressionSemantic proximity Read